Close Menu

Eugene Goldwasser, who isolated and purified erythropoietin in the 1970s, has died, reports The New York Times. He was 88. It later became the basis of Amgen, and the company has made billions of dollars on the anemia drug. "It just continually delighted him that the work he did ended up having an impact on patients," Gary Toback, a colleague of Goldwasser's at the University of Chicago, tells the Times.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.